Ariosa's non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million ...
Labcorp’s testing capabilities are getting a little broader with the $237.5 million acquisition of certain laboratory assets from BioReference Health, a subsidiary of Opko Health. The BioReference ...
Bio-Reference Laboratories is up 81 cents, or 14.6 percent, to $6.37, after the Elmwood Park, N.J., firm reaffirmed its outlook for at least a 100 percent increase in pre-tax net income and a 20 ...
Bio-Reference Laboratories (NASDAQ: BRLI) reported earnings on June 6. Here are the numbers you need to know. The 10-second takeaway For the quarter ended April 30 (Q2), Bio-Reference Laboratories met ...
ELMWOOD PARK, N.J., Aug. 16, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results